In the News
Feb February 21 Wed 2018
Human Immunity to Cas9 Could Threaten CRISPR’s Future
By Dave Roos
New data shows that humans carry antibodies and even T-cells that target the Cas9 protein at the heart of CRISPR gene editing technology.
Oct October 09 Mon 2017
Matthew Porteus awarded grant for sickle cell anemia work
The California Institute for Regenerative Medicine has awarded MATTHEW PORTEUS, associate professor of pediatrics, a grant of $5.2 million to lay the groundwork for a clinical trial of a possible treatment for sickle cell disease.
Nov November 07 Mon 2016
Researchers take step toward gene therapy for sickle cell disease
Using the CRISPR gene-editing technique in stem cells, Stanford researchers repaired the gene that causes sickle cell disease, and the mended stem cells were successfully transplanted into mice.
Read more >>
Jun June 29 Mon 2015
CRISPR marches forward: Stanford scientists optimize use in human blood cells
The CRISPR news just keeps coming. As we’ve described here before, CRISPR is a breakthrough way of editing the genome of many organisms, including humans — a kind of biological cut-and-paste function that is already transforming scientific and clinical research. Read more >>
May May 26 Tue 2015
Porteus receives $1M stem cell grant for ‘bubble boy disease’
The grant will allow the researcher to pursue a stem-cell-based gene therapy approach to correcting a form of severe combined immunodeficiency in humans. Read more >>
Oct October 29 Wed 2014
New way of genome editing could cure hemophilia in mice; may be safer than older method, study shows
A technique developed by Stanford researchers could provide a safer, longer-lasting method of replacing faulty, disease-causing genes with working copies. Read more >>